Bill and Melinda Gates Fund Global Ivermectin & Fluvoxamine Clinical Trial Targeting COVID-19: Together COVID-19 Trial:A Principal Investigator from McMaster University in Ontario leads a large international clinical trial testing drugs targeting COVID-19 including ivermectin, metformin and fluvoxamine. With a growing number of studies indicating the potential efficacy of ivermectin, as well as some evidence that fluvoxamine shows promise, this large study could potentially take the evidence to the next level of credibility. The results of this study could be available within just a few months. The study is funded by the Bill and Melinda Gates Foundation as well as FastGrants.
NIH COVID-19 Treatment Guidelines Panel Updates Position on Ivermectin:The National Institutes of Health (NIH) COVID-19 Treatment Guidelines Panel just updated their guidelines on ivermectin for COVID-19. Essentially the same guidance as their interim guidance posted last month, a couple weeks past their meeting with the leaders of the Front Line COVID-19 Critical Care Alliance (FLCCC) and Dr. Andrew Hill affiliated with the University of Liverpool. However, they included more information.
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).